After demonstrating that miR-92a-3p, miR-320a and miR-320b regulate MAPT, we investigated their differential expression in plasma samples of patients with AD and FTD and their possible roles as diagnostic biomarkers. Here, MAPT is linked to frontotemporal dementia.